GILEAD SCIENCES, INC. Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax
GILEAD SCIENCES, INC. (GILD) reported Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax of $0 for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax · last filed 2018-05-09
- GILEAD SCIENCES, INC. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for the quarter ending 2018-03-31 was $0.00.
- GILEAD SCIENCES, INC. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- GILEAD SCIENCES, INC. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for the quarter ending 2017-09-30 was -$2.00M, a 200.00% decline year-over-year.
- GILEAD SCIENCES, INC. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for the quarter ending 2017-06-30 was -$2.00M.
- GILEAD SCIENCES, INC. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for fiscal 2017 was -$11.00M.
- GILEAD SCIENCES, INC. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- GILEAD SCIENCES, INC. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for fiscal 2015 was $21.00M, a 31.25% increase from fiscal 2014.
- GILEAD SCIENCES, INC. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for fiscal 2014 was $16.00M, a 300.00% increase from fiscal 2013.
| Period end | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax 3 month | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax 3 month as first filed | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax 6 month | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax 6 month as first filed | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax 9 month | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax 9 month as first filed | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax 12 month | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-03-31 | $0.00 10-Q · filed 2018-05-09 | $0.00 derived: sum of 2 quarters · filed 2018-05-09 | -$2.00M derived: sum of 3 quarters · filed 2018-05-09 | -$4.00M derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$2.00M derived: sum of 2 quarters · filed 2018-02-27 | -$4.00M derived: sum of 3 quarters · filed 2018-02-27 | -$11.00M 10-K · filed 2018-02-27 | ||||
| 2017-09-30 | -$2.00M 10-Q · filed 2017-11-07 | -$4.00M derived: sum of 2 quarters · filed 2017-11-07 | -$11.00M 10-Q · filed 2017-11-07 | -$2.00M derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2017-06-30 | -$2.00M 10-Q · filed 2017-08-07 | -$9.00M 10-Q · filed 2017-08-07 | $0.00 derived: sum of 3 quarters · filed 2018-05-09 | $2.00M derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2017-03-31 | -$7.00M 10-Q · filed 2018-05-09 | $2.00M derived: sum of 2 quarters · filed 2018-05-09 | $4.00M derived: sum of 3 quarters · filed 2018-05-09 | $3.00M derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2016-12-31 | $9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $11.00M derived: sum of 2 quarters · filed 2018-02-27 | $10.00M derived: sum of 3 quarters · filed 2018-02-27 | $0.00 10-K · filed 2018-02-27 | ||||
| 2016-09-30 | $2.00M 10-Q · filed 2017-11-07 | $1.00M derived: sum of 2 quarters · filed 2017-11-07 | -$9.00M 10-Q · filed 2017-11-07 | -$2.00M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | -$1.00M 10-Q · filed 2017-08-07 | -$11.00M 10-Q · filed 2017-08-07 | -$4.00M derived: sum of 3 quarters · filed 2018-02-27 | $7.00M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | -$10.00M 10-Q · filed 2017-05-10 | -$3.00M derived: sum of 2 quarters · filed 2018-02-27 | $8.00M derived: sum of 3 quarters · filed 2018-02-27 | $5.00M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | $7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $18.00M derived: sum of 2 quarters · filed 2018-02-27 | $15.00M derived: sum of 3 quarters · filed 2018-02-27 | $21.00M 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $11.00M 10-Q · filed 2016-11-07 | $8.00M derived: sum of 2 quarters · filed 2016-11-07 | $14.00M 10-Q · filed 2016-11-07 | $24.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-30 | -$3.00M 10-Q · filed 2016-08-05 | $3.00M 10-Q · filed 2016-08-05 | $13.00M derived: sum of 3 quarters · filed 2017-02-27 | $19.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-31 | $6.00M 10-Q · filed 2016-05-06 | $16.00M derived: sum of 2 quarters · filed 2017-02-27 | $22.00M derived: sum of 3 quarters · filed 2017-02-27 | $20.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $16.00M derived: sum of 2 quarters · filed 2017-02-27 | $14.00M derived: sum of 3 quarters · filed 2017-02-27 | $16.00M 10-K · filed 2017-02-27 | ||||
| 2014-09-30 | $6.00M 10-Q · filed 2015-11-04 | $6.46M 10-Q · filed 2014-11-05 | $4.00M derived: sum of 2 quarters · filed 2015-11-04 | $6.00M 10-Q · filed 2015-11-04 | $6.29M 10-Q · filed 2014-11-05 | $7.50M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-06-30 | -$2.00M 10-Q · filed 2015-08-05 | -$1.91M 10-Q · filed 2014-08-04 | $0.00 10-Q · filed 2015-08-05 | -$174.00K 10-Q · filed 2014-08-04 | $1.50M derived: sum of 3 quarters · filed 2016-02-24 | $7.58M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-03-31 | $2.00M 10-Q · filed 2015-05-08 | $1.73M 10-Q · filed 2014-05-07 | $3.50M derived: sum of 2 quarters · filed 2016-02-24 | $9.58M derived: sum of 3 quarters · filed 2016-02-24 | $11.31M derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2013-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $7.58M derived: sum of 2 quarters · filed 2016-02-24 | $9.31M derived: sum of 3 quarters · filed 2016-02-24 | $4.00M 10-K · filed 2016-02-24 | $4.34M 10-K · filed 2014-02-25 | |||
| 2013-09-30 | $6.08M 10-Q · filed 2014-11-05 | $7.81M derived: sum of 2 quarters · filed 2014-11-05 | $2.50M 10-Q · filed 2014-11-05 | $7.50M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-06-30 | $1.73M 10-Q · filed 2014-08-04 | -$1.73M 10-Q · filed 2013-08-01 | $3.58M 10-Q · filed 2014-08-04 | -$3.58M 10-Q · filed 2013-08-01 | $1.42M derived: sum of 3 quarters · filed 2015-02-25 | $4.60M derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-03-31 | -$1.85M 10-Q · filed 2014-05-07 | -$309.00K derived: sum of 2 quarters · filed 2015-02-25 | $2.87M derived: sum of 3 quarters · filed 2015-02-25 | -$1.20M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2012-12-31 | $1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $4.72M derived: sum of 2 quarters · filed 2015-02-25 | $646.00K derived: sum of 3 quarters · filed 2015-02-25 | $2.00M 10-K · filed 2015-02-25 | $1.57M 10-K · filed 2013-02-27 | |||
| 2012-09-30 | $3.18M 10-Q · filed 2013-10-31 | -$894.00K derived: sum of 2 quarters · filed 2013-10-31 | $460.00K 10-Q · filed 2013-10-31 | -$2.55M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-06-30 | -$4.07M 10-Q · filed 2013-08-01 | -$2.32M 10-Q · filed 2013-08-01 | -$5.73M derived: sum of 3 quarters · filed 2014-02-25 | -$10.76M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-03-31 | $1.80M 10-Q · filed 2013-05-08 | -$1.66M derived: sum of 2 quarters · filed 2014-02-25 | -$6.69M derived: sum of 3 quarters · filed 2014-02-25 | -$4.08M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2011-12-31 | -$3.46M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | -$8.49M derived: sum of 2 quarters · filed 2014-02-25 | -$5.88M derived: sum of 3 quarters · filed 2014-02-25 | -$93.00K 10-K · filed 2014-02-25 | $93.00K 10-K · filed 2012-02-23 | |||
| 2011-09-30 | -$5.03M 10-Q · filed 2012-11-06 | -$2.42M derived: sum of 2 quarters · filed 2012-11-06 | $3.37M 10-Q · filed 2012-11-06 | |||||
| 2011-06-30 | $2.61M 10-Q · filed 2012-08-01 | $101.00K 10-Q · filed 2012-08-01 | ||||||
| 2011-03-31 | $1.17M 10-Q · filed 2012-05-04 | |||||||
| 2010-12-31 | -$9.15M 10-K · filed 2013-02-27 | |||||||
| 2009-12-31 | -$10.68M 10-K · filed 2012-02-23 | $10.68M 10-K · filed 2011-02-28 | ||||||
| 2008-12-31 | -$40.68M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |